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Abstract
Background: Telomeres are involved in cellular ageing and shorten with increasing age. If telomere length is a valuable
biomarker of ageing, then telomere shortening should be associated with worse physical performance, an ageing trait, but
evidence for such an association is lacking. The purpose of this study was to examine whether change in telomere length is
associated with physical performance.
Methods: Using data from four UK adult cohorts (ages 53–80 years at baseline), we undertook cross-sectional and
longitudinal analyses. We analysed each study separately and then used meta-analytic methods to pool the results. Physical
performance was measured using walking and chair rise speed, standing balance time and grip strength. Telomere length
was measured by quantitative real-time polymerase chain reaction (PCR) in whole blood at baseline and follow-up (time 1,
time 2).
Results: Total sample sizes in meta-analyses ranged from 1,217 to 3,707. There was little evidence that telomere length was
associated with walking speed, balance or grip strength, though weak associations were seen with chair rise speed and grip
strength at baseline (p = 0.02 and 0.01 respectively). Faster chair rise speed at follow-up, was associated with a smaller
decline in telomere length between time 1 and time 2 (standardised coefficient per SD increase 0.061, 95% CI 0.006, 0.115,
p= 0.03) but this was consistent with chance (p= 0.08) after further adjustment.
Conclusions: Whereas shortening of leukocyte telomeres might be an important measure of cellular ageing, there is little
evidence that it is a strong biomarker for physical performance.
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Introduction
Telomeres are nucleoprotein complexes at chromosome ends,
where the DNA component is a repetitive stretch of (TTAGGG),
which caps and protects the end of the chromosome. Since
telomeres are involved in cellular ageing and shorten with
increasing age, it has been proposed that telomere length could
be a useful biomarker of ageing [1]. Whereas some studies have
shown that shorter telomeres are associated with obesity [2], male
gender [3], lower socioeconomic position [4] and current smoking
[5], evidence that telomere length is a biomarker of ageing is
equivocal [1]. Although some studies have shown that shorter
telomeres are associated with increased mortality rates [6], others
have not shown an association [7]. In addition, no evidence of an
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association between telomere length and frailty was found in a
study of adults aged 65 years and older even though the frailty
index (physical, psychological and functional domains) is suppos-
edly a good measure of biological ageing [8].
Physical performance can be assessed using simple, objective
measures such as chair rise time, grip strength, standing balance
and walking speed [9]. Furthermore, reduced performance in each
of these measures is a predictor of all cause mortality [9]. We are
aware of only four studies which have examined the associations
between telomere length and objective measures of physical
performance [10–13]. None of these studies found evidence of an
association between telomere length and grip strength [10–13].
Furthermore, no evidence of an association was observed between
telomere length and walking speed in the two studies which have
examined this [11,12]. A limitation of these four studies is that they
are cross-sectional and did not examine chair rise time or standing
balance.
We have undertaken an individual participant data (IPD) meta-
analysis [14] using four cohorts, including new unpublished data,
as part of the Healthy Ageing across the Life course (HALCyon)
programme, to assess the associations between telomere length
and four physical performance tests. Each cohort has repeat
telomere length measures (time 1 and time 2), with the period
between times ranging from 7.5 to 10.2 years. Our approach has
several advantages: (a) ability to examine whether age-related
changes in telomere length are associated with physical perfor-
mance; (b) greater statistical power to detect modest associations;
(c) standardising analyses by handling covariates and physical
performance measures in the same way across studies. The aims of
this study were to investigate whether longer telomeres were
associated with: (1) better physical performance in cross-sectional
analyses, (2) better future physical performance in prospective
analyses, whether (3) telomere length at baseline predicted change
in physical performance and whether (4) change in telomere length
was associated with better physical performance at follow-up.
Methods
The Cohorts
The Healthy Ageing across the Life Course (HALCyon)
programme is a cross-cohort study on ageing. We have included
data from four of the nine UK cohort studies involved in
HALCyon which have data on both telomere length and physical
performance. These were the Caerphilly Prospective Study (CaPS)
[15], the Hertfordshire Ageing Study (HAS) [16], the Lothian
Birth Cohort 1921 (LBC1921) [17] and the MRC National Survey
of Health and Development (NSHD) [18,19]. (Appendix S1).
Ethics Statements
Ethical approval was given for the CaPS by the Ethics
Committee of the Division of Medicine of the former South
Glamorgan Area Health Authority. Approval for phase 5 came
from the South East Wales Research Ethics Committee. For HAS,
ethical approval was given by the Bedfordshire and Hertfordshire
Local Research Ethics Committee and the West Hertfordshire
Local Research Ethics Committee. Ethical approval was given for
LBC1921 by the Multicentre Research Ethics Committee for
Scotland and the Lothian Research Ethics Committee. Ethical
approval for NSHD was given by the North Thames Multi-Centre
Research Ethics Committee (age 53 y) and the Central Manche-
ster Research Ethics Committee and the Scottish A Research
Ethics Committee (age 60–64).
Data Availability
Data access for CaPS is available via a request to the data
steering committee (see http://www.bris.ac.uk/social-community-
medicine/projects/caerphilly/). Bona fide researchers can apply
to access the HAS data via a standard application procedure
(further details available at : http://www.mrc.soton.ac.uk). Bona
fide researchers can apply to access the LBC1921 data via a
standard application procedure. Further details available in the
open accessed article [17]. Bona fide researchers can apply to
access the NSHD data via a standard application procedure
(further details available at : http://www.nshd.mrc.ac.uk/data.
aspx).
Physical Performance Measures
Different tests were available at baseline and follow-up across
the four cohorts (Appendix S2).
Walking speed. In CaPS and NSHD, the time to get up from
a chair, walk 3 m at normal speed, turn around, walking back and
sitting down was recorded (TUG test) [20]. In HAS, participants
walked at a normal pace over a 3 m course. In LBC1921
participants walked as quickly but as safely as possible over a 6 m
course and the times recorded. In HAS, LBC1921 and NSHD one
trial was performed and in CaPS two trials were performed and
the average value used.
Chair rises. The time taken for participants to stand up from
a chair and sit down as fast as possible five times in HAS and ten
times in NSHD, was recorded.
Grip strength. Dynamometers were used to record either
two (NSHD) or three (HAS) measures in each hand or three
measures in the dominant hand (LBC1921). In each of the cohorts,
maximum grip strength (kg) achieved was used in analyses.
Standing balance. In each of the cohorts, standing balance
was the longest time up to 30 s that a participant could stand on
one leg with eyes open. One trial was performed in HAS and
NSHD and two trials were performed in CaPS (with the best value
used).
Harmonisation of physical performance measures. To
take account of the different protocols used in assesssing physical
performance across cohorts, we harmonised these measures [21].
Walking times were converted into walking speed (metres/minute)
and chair rise times were converted into chair rise speed (stands/
minute) and these measures were standardised by computing
study-specific z-scores. Balance time was dichotomised with those
in the bottom 20th centile classified with poor balance and
compared with the rest of the participants.
Telomere Length Measures
Telomere length was measured by quantitative real-time
polymerase chain reaction (PCR) in whole blood DNA as
abundance of telomeric template versus a single gene [7]. All
measurements were undertaken in the same laboratory. Measure-
ments were performed in quadruplicate on an Applied Biosystems
7900 HT Fast Real Time PCR system with 384-well plate
capacity. The intra-assay coefficient of variation was 2.7% while
the inter-assay coefficient of variation was 5.1%. To correct for
inter-plate variation, four internal control DNA samples of known
telomere length were run within each plate and used to generate a
regression line by which values of relative telomere length for the
actual samples were converted into absolute telomere lengths in
base pairs. For details of primer sequences (including telomeric
primers and control gene primers) and a description of the DNA
isolation methods see Appendix S3.
Telomere Length and Physical Performance
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Clinical and Questionnaire-based Data
Potential confounders were identified a priori based on existing
literature (age [22], gender [23], adiposity [2], smoking status [5],
socioeconomic position [4] and health status [24,25]). Anthropo-
metric measures were taken at clinic or nurse home visits.
Standing height was measured to the nearest mm using a
stadiometer and weight was measured in kilograms (Kg) using
standardised scales. Body Mass Index (BMI) was calculated as
weight divided by height2 (kg/m2) and was used as a measure of
adiposity. Smoking behaviour was assessed by self-completed
questionnaire (CaPS) or medical interview (HAS, LBC1921 and
NSHD). Smoking status was classified into never, past or current.
In CaPS, HAS and NSHD, socioeconomic position was defined by
the British Registrar General’s classification of occupation and
based on own occupation in adult life. In LBC1921, occupational
social class was assessed using the standard UK Classification of
Occupations, placing occupation into five categories [11]. This
was based on their own highest ranked occupation, or for married
women their husband’s. In CaPS, HAS and NSHD, lower
socioeconomic position was classified as manual (skilled manual,
semi-skilled manual and unskilled) and in LBC1921, it was
classified as the three non-professional classes. For health status,
reported history of cardiovascular disease and diabetes was
available in all of the cohorts and reported history of cancer was
available in CaPS, LBC1921 and NSHD. Additional health status
data was available in LBC1921 (cerebrovascular disease and
dementia) and in NSHD (epilepsy). Poor health status was defined
as having one or more of the specified health conditions.
Statistical Analysis
We used linear regression models to analyse walking speed,
chair rise speed and grip strength and logistic regression analysis
for standing balance. To take account of protocol variability in
blood storage, DNA extraction and measurement of telomere
length, we converted the absolute measures to study-specific z-
scores. We adjusted the final model for all potential confounders
(age, gender, BMI, smoking status, socioeconomic position and
health status).
We undertook a series of analyses: (a) cross-sectional analyses
between telomere length and physical performance at time 1, (b)
cross-sectional analyses between telomere length and physical
performance at time 2, (c) prospective analyses between telomere
length at time 1 and physical performance at time 2, (d) analyses of
change in telomere length in relation to physical performance at
time 2 (this examined physical performance at time 2 with
telomere length at time 2 conditional on time 1) and (e) analyses of
telomere length at time 1 in relation to longitudinal changes in
physical performance. This last analysis regressed physical
performance at time 2 on telomere length at time 1 and adjusted
for physical performance at time 1. Standing balance times were
highly skewed and change in standing balance was only possible in
NSHD. To identify change in standing balance time we derived a
three-level ordinal variable, with the inability to balance for more
than or equal to ,5 s as the criteria for poor balance. Those with
good balance (i.e. times $5 s) at times 1 and 2 were used as the
baseline group and coded as 0, those who ‘improved’ (i.e. had poor
balance at time 1 but not at time 2) (n = 38) were also included in
this category, those whose performance declined (i.e. had good
Table 1. Characteristics of the participants at time 1 and time 2, by study.
Variable CaPS HAS LBC1921 NSHD
N{ 966 656 493 2558
Gender (% male) 100 69.4 48.8 46.7
Age at time 1 (years) 64.5 (4.1) 67.0 (2.2) 79.1 (0.6) 53.4 (0.2)
Age at time 2 (years) 72.8 (3.9) 76.3 (2.2) 86.6 (0.4) 62.7 (1.0)
BMI (Kg/m2) 27.3 (3.6) 26.9 (3.6) 25.9 (4.1) 26.9 (4.1)
Current smoker (%) 17.6 8.0 2.4 17.6
Lower SEP (%) 59.5 46.2 36.0 22.6
Lower Health Status (%) 47.5 27.1 35.2 8.6
Telomere length at time 1 (kb) 4.3 (1.6) 5.2 (1.6) 4.1 (0.4) 5.6 (1.9)
Telomere length at time 2 (kb) 3.3 (1.3) 3.9 (1.3) 4.2 (0.6) 4.3 (1.3)
Walking speeda (m/min) – 51.3 (9.9) 66.6 (24.1) –
TUG speedb (m/min) 35.7 (7.4) – – 42.3 (8.4)
Standing balancec (s) 15.7 (4.8–30) 10.3 (4.0–27.6) – 30 (12.3–30)
cut-point (bottom 20%) (s) 3.8 3.0 – 9.1
Chair rise speedd (stands/min) – 16.1 (4.4) – 25.6 (7.4)
Grip strength (Kg)
Males – 39.1 (7.9) 28.6 (7.3) 47.1 (11.7)
Females – 24.4 (7.0) 15.4 (4.0) 27.4 (7.5)
{N is the maximum sample size in age and sex adjusted analyses at either time 1 or time 2. Results are presented as mean (SD), unless otherwise stated and are based on
complete case analysis. Physical performance measures are taken from time 1. Covariates are given at time 1 unless otherwise stated. Health status was at time 2 in
CaPS.
aWalking speed in HAS is based on a 3 m walk at normal page and in LBC1921 it is a 6 m walk undertaken as quickly but as safely as possible.
bWalking speed in CaPS and NSHD is based on the get up and go test (TUG), which involves walking 6 m at a normal pace.
cStanding balance in CaPS, HAS and NSHD is a one-legged stand for 30 s. Median balance times (and inter-quartile range) and cut-point times for bottom 20% are given.
dChair rise speed in stands/minute is calculated as the number of stands (5 in HAS and 10 in NSHD)/time taken for those stands.
doi:10.1371/journal.pone.0069526.t001
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balance at time 1 but poor balance at time 2) were coded as 1 and
those with consistently poor balance were coded as 2. We then
undertook ordered logistic regression using this outcome variable.
We undertook a two stage meta-analysis of individual partic-
ipant data with each model initially run within each cohort (the
first stage). The cohort-specific effect estimates and standard errors
were then pooled using meta-analysis (the second stage). We
performed random-effects meta-analyses using the DerSimonian
and Laird method [26] as our a priori was that there would be
heterogeneity due to differences in measurement protocols. In
model A we adjusted for age and gender and in model B
additionally for BMI, smoking status, socioeconomic position and
health status. We investigated between study heterogeneity using
the I2 statistic [27]. We plotted Forest plots in the order of mean
age and re-ran meta-analyses with each study taken out in turn to
see whether this influenced the I2 statistic.
We undertook a series of sensitivity analyses: a) excluding any
cohorts which were outliers, b) modelling telomere length in three
equal groups (tertiles), c) inclusion of subjects unable to perform
the physical performance tests who are initially excluded due to
missing outcome data, d) computing sex-specific z-scores for
walking speed and chair rise speed, e) using less than 5 s as the
criterion for poor balance, f) using the TUG test rather than the
3 m walk test for HAS and g) using the continuous standing
balance time score with eyes closed in the analysis for change in
balance time for NSHD (Appendix S4).
Results
Descriptive characteristics of the four studies are shown in
Table 1. Age range was from 53 to 80 years at time 1, the youngest
cohort being NSHD and the oldest LBC1921. The median time
lag and inter-quartile range between times 1 and 2 ranged from
7.5 (7.3–7.8) years in LBC1921 to 10.2 (9.3–10.8) years in NSHD.
Variation in mean walking speeds between cohorts was partly due
to the difference between studies in the protocols for this test.
Meta-analyses
Total sample size in the age and sex-adjusted models varied
between 1,217 and 3,707 depending on the meta-analysis
(Table 2). Associations between telomere length and physical
performance from meta-analyses are detailed in Table 2, Figure 1,
Figure 2 and Appendix S5.
Walking speed. No association was observed in cross-
sectional analyses at time 1 or time 2 between telomere length
and walking speed (Table 2). Furthermore, there was little
evidence of an association between either telomere length at time
1 and walking speed at time 2 (Table 2), or between change in
telomere length and walking speed at time 2 (Table 2; Figure 1).
Longer telomeres at time 1 were weakly associated with less
decline in walking speed even after full adjustment (p=0.16;
Table 2), although this result was based on just one study
(LBC1921).
Chair rise speed. Longer telomeres at time 1 were
associated with quicker chair rise speed at time 1 (Table 2),
Figure 1. Meta-analysis for the association between telomere length at time 2 conditional on telomere length at time 1 and walking
speed at time 2 adjusted for age and sex.
doi:10.1371/journal.pone.0069526.g001
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although this result was based on one study (NSHD). In cross-
sectional associations at time 2, longer telomeres were weakly
associated with quicker chair rise speed (p=0.06 in age and sex
adjusted models and p=0.13 in the fully adjusted model, Table 2).
A smaller decline in telomere length between time 1 and time 2
was associated with a quicker chair rise speed when age and sex
adjusted (p = 0.03; Figure 2), weakly attenuated when fully
adjusted (p=0.08). There was no evidence of an association
between telomere length at time 1 and chair rise speed at time 2
(Table 2), or between telomere length at time 1 and change in
chair rise speed (Table 2).
Standing balance. There was no evidence of an association
in cross-sectional analyses between telomere length at either time 1
or time 2 and balance (Table 2), nor between telomere length at
time 1, or change in telomere length and balance at time 2
(Table 2). Moreover, there was little evidence of an association
between telomere length at time 1 and change in balance time
(Table 2).
Grip strength. Whilst there was little evidence of cross-
sectional associations at time 1 between telomere length and grip
strength when age and sex adjusted (p = 0.49), longer telomeres at
time 1 were associated with stronger grip strength at time 1 after
further adjusting for BMI, smoking status, socioeconomic position
and health status (p = 0.01). This was mainly due to the effect of
further adjustments for smoking status and health status in HAS,
associations which were initially weakly negative becoming weakly
positive, albeit consistent with chance. There was little evidence of
an association between telomere length and grip strength in cross-
sectional analyses at time 2 (Table 2). There was no evidence of an
association between telomere length and grip strength in
prospective analyses.
Heterogeneity
There was evidence of moderate heterogeneity between studies
in age and sex-adjusted meta-analyses of telomere length and
walking speed (I2 = 36.0% to 69.3%) and telomere length and grip
strength (I2 = 36.2% to 68.4%). Omitting the LBC1921 cohort
from the meta-analyses of associations between telomere length at
time 1 and walking speed at time 2 (I2 = 36.0% to 13.0%) and
between telomere length at time 1 and grip strength at time 2
(I2 = 36.2% to 0.0%), resulted in a reduction in the level of
heterogeneity. Omitting the LBC1921 cohort from associations
between telomere length at time 1 and grip strength at time 1
resulted in an increase in the level of heterogeneity (I2 = 68.4% to
84.1%). Removal of each study in turn from the remaining meta-
analyses did not greatly effect the level of heterogeneity (data not
shown).
Sensitivity Analyses
We found little effect on the meta-analyses for a wide range of
sensitivity analyses which did not alter our main conclusions
(Appendix S4).
Discussion
In general there was little evidence that telomere length – or
maintenance of telomere length over time – was associated with
Figure 2. Meta-analysis for the association between telomere length at time 2 conditional on telomere length at time 1 and chair
rise speed at time 2 adjusted for age and sex.
doi:10.1371/journal.pone.0069526.g002
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walking speed, balance or grip strength in either cross-sectional or
prospective analyses. Our results show that change (smaller
decline) in telomere length was associated with quicker chair rise
speed at time 2 (where time period between time 1 and time 2
ranged from 7.5 years to 10.2 years) but this was consistent with
chance in the fully adjusted model. There was some modest
evidence that longer telomeres were associated with quicker chair
rise speed at time 1 and time 2 in the partially adjusted model.
There was some evidence that longer telomeres were associated
with stronger grip strength at time 1 after full adjustment. There
was also weak suggestive evidence that telomere length at time 1
was associated with worsening walking speed in prospective
analysis but this was consistent with chance in the fully adjusted
model.
Our lack of associations between telomere length and grip
strength or walking speed are consistent with the literature [10–
13], with data from LBC1921 [11] included in our study. We are
not aware of any studies which have examined the associations
between telomere length and either balance or chair rise speed.
We found weak evidence of an association between change in
telomere length and faster chair rise speed but this could be due to
a type I error. The lack of consistency across our various
performance measures may be explained by the fact that they are
measuring different underlying components of performance. Grip
strength is a measure of upper body isometric strength [28], whilst
balance, chair rising and walking require lower body strength,
balance, postural and motor control [9]. Walking speed and chair
rises are more dynamic measures than balance and additionally
Table 2. Overall summary estimates of effect for the associations between telomere length (TL) at times 1 and 2 and physical
performance (PP) at times 1 and 2 from random effects meta-analyses.
Model A Model B
Outcome (PP) and
(Age, sex
adjusted)
(Fully
adjusted``)
telomere length (T)** No* b{ 95% CI P -value I2 P- value` b{ 95% CI P- value I2 P -value`
Walking speed{{ (sd score)
T1-PP1 (n = 491) 1 0.019 20.075, 0.112 0.70 0.020 20.075, 0.116 0.67
T2-PP2 (n = 2319) 4 0.013 20.060, 0.086 0.73 66.8% 0.03 0.027 20.037, 0.091 0.41 56.8% 0.07
T1-PP2 (n = 2907) 4 0.016 20.033, 0.065 0.52 36.0% 0.20 0.011 20.031, 0.053 0.61 18.2% 0.30
T2T1-PP2 (n = 2021) 4 0.022 20.058, 0.101 0.60 69.3% 0.02 0.026 20.047, 0.099 0.48 62.7% 0.05
T1-DPP (n = 144) 1 0.121 20.021, 0.263 0.09 0.109 20.043, 0.260 0.16
Chair rise speed (sd score)
T1-PP1 (n = 2447) 1 0.041 0.001, 0.080 0.04 0.046 0.006, 0.085 0.02
T2-PP2 (n = 1236) 2 0.052 20.003, 0.106 0.06 0.0% 0.72 0.042 20.012, 0.097 0.13 0.0% 0.96
T1-PP2 (n = 2025) 2 0.004 20.039, 0.047 0.87 0.0% 0.92 0.008 20.035, 0.051 0.71 0.0% 0.80
T2T1-PP2 (n = 1217) 2 0.061 0.006, 0.115 0.03 0.0% 0.70 0.049 20.006, 0.104 0.08 0.0% 0.72
T1-DPP (n = 1711) 1 20.016 20.059, 0.027 0.47 20.012 20.055, 0.030 0.57
Odds of poor balance
T1-PP1 (n = 2578) 1 0.97 0.87, 1.07 0.53 0.95 0.85, 1.05 0.31
T2-PP2 (n = 2239) 3 1.01 0.91, 1.11 0.93 0.0% 0.64 1.02 0.91, 1.14 0.79 0.0% 0.80
T1-PP2 (n = 2844) 3 1.03 0.94, 1.13 0.52 0.0% 0.63 1.02 0.92, 1.13 0.69 0.0% 0.61
T2T1-PP2 (n = 1949) 3 1.00 0.90, 1.12 0.99 0.0% 0.41 0.99 0.87, 1.11 0.82 0.0% 0.71
T1-DPP (n = 1809) 1 1.09 0.95, 1.25 0.20 1.09 0.95, 1.26 0.21
Grip strength (Kg)
T1-PP1 (n = 3707) 3 0.176 20.321, 0.673 0.49 68.4% 0.04 0.391 0.090, 0.693 0.01 0.0% 0.48
T2-PP2 (n = 1386) 3 0.230 20.403, 0.863 0.48 42.7% 0.18 0.243 20.450, 0.936 0.49 46.5% 0.16
T1-PP2 (n = 2208) 3 0.099 20.424, 0.622 0.71 36.2% 0.21 0.201 20.304, 0.706 0.44 27.2% 0.25
T2T1-PP2 (n = 1362) 3 0.301 20.383, 0.985 0.39 46.6% 0.15 0.216 20.286, 0.717 0.40 3.8% 0.35
T1-DPP (n = 2152) 3 20.059 20.383, 0.265 0.72 0.0% 0.59 0.026 20.310, 0.361 0.88 0.0% 0.42
n= Sample size in age and sex adjusted analyses;
*Number of studies in analyses;
**T1 and T2 are telomere lengths at times 1 and 2 respectively. PP1 and PP2 are physical performance measures at times 1 and 2 respectively.
{{Walking speed includes TUG measures in CaPS and NSHD. T2T1 is telomere length at time 2 conditional on telomere length at time 1 and is a measure of change in
telomere length given the initial level. DPP is conditional change in physical performance between time 1 and time 2;
{Mean difference in standardised walking speed; Mean difference in standardised chair rise speed; Odds Ratio of poor balance (lowest 20%). For change in balance in
NSHD an ordinal group was created for balance from time 1 to time 2 where good balance was balancing $5 s and poor balance for ,5 s. Here good-good is the
baseline group (0) (including poor-good balance), good-poor (1) and poor-poor (2); Mean difference in grip strength;
`P-value is obtained from the heterogeneity x2;
``Fully adjusted model is for age, sex, BMI, smoking status, SEP and health status; Telomere length measures at times 1 and 2 have been z-scored. Random effects meta-
analyses were undertaken.
doi:10.1371/journal.pone.0069526.t002
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require leg muscle power (to generate a force quickly) [29]. As the
chair rise test makes more demands on cardiorespiratory function
than the other measures this might explain the observed
differences.
Oxidative stress shortens telomeres [30] and the oxidative stress
hypothesis of ageing proposes that oxygen radicals affect ageing
and a wide range of diseases [31]. Oxidative stress is thus expected
to affect many aspects of human health, including physical
performance measures [12]. Indeed, in LBC1921 (79 year olds)
[32] oxidative stress genes were associated with both telomere
length and grip strength. Oxidative stress might thus be a common
underlying cause. LBC1921 had almost no chronological age
variation, which might have facilitated finding an effect of
telomere length, though the same is true of the younger NSHD
birth cohort. The previous LBC1921 analysis only examined grip
strength [32], hence the results might not be generalisable to other
age groups or physical performance measures.
Shortening of leukocyte telomeres might be an important
measure of cellular ageing [8,32] but there is little evidence that
leukocyte telomere length is a bio-aging marker for physical
performance [1,33]. It has been argued that telomere length
should be measured in the tissue relevant for the physical
perfomance measure being undertaken [13], for example in
muscle cells. Whereas associations have been found between
telomere length in leukocytes and skin or synovial cells [34], in
peripheral blood mononuclear cells and fibroblast cells [24] and in
cerebral cortex and liver cells [35], there was no evidence of an
association between telomere length in white blood cells and
buccal cells [36].
Strengths and Limitations
This is the only pooled study which has looked into the
association between telomere length and physical performance
and includes three unpublished datasets. We have overcome the
limitation of previous cross-sectional studies by using repeat
measures of telomere length and physical performance to
undertake prospective analyses. The individual participant data
meta-analysis enabled us to conduct comparable analyses across
studies. We adjusted for age, BMI, smoking status and socio-
economic position as potential confounders in a standardised
fashion but we cannot exclude the possibility of residual
confounding. Indeed, some potential confounders including
physical fitness (e.g. VO2 max) [37,38] could not be taken into
account as they had not been measured in the HALCyon cohorts.
A further strength was that we examined four different objective
measures of physical performance. Telomere length was measured
by the same group for all four cohorts and there were a series of
methodological checks. Inter-assay coefficients of variation were
measured repeatedly and were always found to be below 6%.
Plate-to-plate efficiency variation was below 1% for the reference
gene PCR and below 3% for telomere PCR. Furthermore the
intra-plate single-well efficiency coefficient of variation was below
3%.
Although we have pooled the data from four cohorts, we still
may be underpowered. There was some evidence of moderate
heterogeneity between studies. One possible source of heteroge-
neity is the difference between protocols for assessing physical
performance and to overcome such differences we harmonised the
measures. Furthermore, with such a small number of studies, there
will be large 95% confidence intervals on the I2 estimate of
heterogeneity. We undertook sensitivity analyses by including
participants unable to complete the walking speed, chair rise
speed, grip strength or balance tests in the bottom 20% and
repeating the analysis but this made little difference to the results.
Telomere length measurements made in the four cohorts used
in this study yielded highly consistent and reproducible results.
Previously, the high throughput qPCR methodology used in these
analyses has been criticised that it is not sufficiently reproducible
and insufficiently sensitive. In a direct and blinded comparison
with Southern blot methodology, using the same 50 DNA samples,
qPCR correlated highly (r values .0.9), but the inter-assay CV
measurement for the qPCR was 6.45%, and only 1.74% for
Southern blotting [39]. In the present analyses, the inter-assay CV
was consistently below 6%, in keeping with the majority of
observations in the field made using this methodology. Hence,
assay sensitivity and reproducibility do not appear to be major
issues in this study.
Conclusions
Whilst leukocyte telomere length might be a biomarker for
cellular ageing, we found only weak evidence that it is a bio-aging
marker for physical performance. This is in spite of our relatively
large sample size and having repeat measures of telomere length.
Whilst we cannot exclude a modest association, we believe that a
strong association is unlikely though this may not be true for more
specific tissues, such as muscle cells. The use of telomere length for
screening or targeting interventions to reduce decline in physical
performance is unlikely to be helpful.
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